Reaction

Pulmonary Septal Thickening reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 89 reports · 3 co-occurring drugs

As of the last recalculation, Pulmonary Septal Thickening appears in 89 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is FOSAPREPITANT DIMEGLUMINE (PRR 235.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Fosaprepitant Dimeglumine12235.7235.9
Canakinumab8189.9190.0
Aprepitant12175.5175.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.